Price Position and Structural State
SPDR S&P Biotech ETF (XBI) closed at 162.5 USDT on August 30, 2026, down 0.83%. The asset now sits in a sideways structure near the top of its 55-day range. Current 55-day support is near 143.85 USDT, with resistance near 170.55 USDT. A daily close above 170.55 USDT would confirm an upside regime shift. A rejection near resistance would keep price inside the range.
Moving Averages and Trend Context
XBI is trading below short-term moving averages while still holding above longer-term support. MA20 at 162.555 USDT may cap short-term recovery attempts, while MA50 at 156.764 USDT remains the more significant structural support area. The structure resembles a pullback within a broader trend more than a full trend failure.
Trading Friction and Price Efficiency
XBI shows moderate trading friction, with a 3-day friction score of 45.5. The score combines price progress, wick rejection, and volume confirmation. Recent candles show mixed acceptance, so price is moving but still showing some noise. Moves near support or resistance need a cleaner daily close before they carry stronger weight.
Open Interest, Funding, and Positioning
Open interest data is limited for this asset, so the leverage range cannot be judged reliably yet. This makes futures participation harder to compare with recent history.
Funding is near neutral across the 24-hour and 7-day averages, at 0.000000% and 0.000000%. This shows limited cost pressure on either side, so funding is not giving a strong directional signal right now.
The long/short ratio is 1.54, showing more long accounts than short accounts. It sits near the middle of its 60-day range, so this is a long tilt without clear historical crowding.
Correlation, Beta, and Index Relationship
XBI shows a moderate relationship with the broader crypto market (Sigloid Index). Correlation indicates partial co-movement with the index, while R² suggests that index behavior explains only part of its movement. This means broader market direction has some influence, but asset-specific factors remain important. Over the 30-day window, the relationship is weakening.
| Window | Correlation | Beta | R² | Read |
|---|---|---|---|---|
| 30D | 0.415 | 0.279 | 0.172 | Moderate linkage |
| 60D | — | — | — | Not enough data |
| 180D | — | — | — | Not enough data |
Momentum, Volatility, and Indicator Pressure
XBI's volatility profile is controlled rather than stretched. ATR% reads 2.78, near the lower side of its full historical range. Bollinger Band width% reads 10.38, near the middle of its full historical range. 20-day Volume Z-score is -0.99. Range expansion is not leading the setup right now.
ROC14 is +4.08%, while RSI is 49.20 and MACD histogram remains negative. Multi-day acceleration has improved, but the broader momentum picture is still incomplete.
The read is still incomplete: momentum is improving, but volatility or participation has not confirmed the move strongly enough.
Broader Market Regime
The Sigloid Index remains in a bullish regime, showing broad strength across the market. XBI has a moderate link to that market condition, so market strength can still influence price behavior, while asset specific factors also matter.
Key Levels for the Next State Change
For XBI, the next structural shift depends on range boundaries. A daily close above 55-day resistance at unavailable establishes a bullish regime, while a daily close below 55-day support at unavailable confirms a bearish regime.